COMMUNIQUÉS West-GlobeNewswire

Fagron NV: Fagron shareholders approve all proposed resolutions
14/05/2019
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), May 14 th , 2019 - 7:00am CET Fagron shareholders approve all proposed resolutions Fagron announces today that the annual general meeting of [...]
TOMI Environmental Solutions, Inc. to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 20, 2019
14/05/2019
BEVERLY HILLS, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials announced it will hold its [...]
Applied Therapeutics Announces Pricing of Initial Public Offering
14/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/05/2019
WALTHAM Mass. and CRESTWOOD, Ky., May 13, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Axcella Health Announces Closing of Initial Public Offering
13/05/2019
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and [...]
Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors
13/05/2019
CRANBURY, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment of Burke W. Whitman to its Board of Directors, effective at the end of this quarter. Mr. [...]
DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
Phase Ib study of DM199 in Chronic Kidney Disease nearing full enrollment Completion of new cGMP manufacturing run of DM199 Conference call with management tomorrow, May 14, 2019 at 7am CT MINNEAPOLIS, May 13, 2019 ( [...]
T2 Biosystems Reports Granting of Inducement Awards
13/05/2019
LEXINGTON, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year
13/05/2019
Strong fourth quarter revenue growth Fourth quarter earnings improve to $1.27 per diluted share as reported; adjusted earnings per diluted share increase to $1.53 Full year fiscal 2019 revenue growth and adjusted [...]
Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, May 14th to Discuss Results from Phase 3 LIBERTY 1 Study Evaluating Once Daily Relugolix Combination Therapy in Women with Uterine Fibroids
13/05/2019
BASEL, Switzerland, May 13, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE:MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s health and prostate [...]
LHC Group to Present at Three Healthcare Conferences in May
13/05/2019
LAFAYETTE, La., May 13, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that over the next two weeks the Company is presenting at the Bank of America Merrill Lynch 2019 Health Care Conference in [...]
Homology Medicines Reports First Quarter 2019 Financial Results and Recent Highlights
13/05/2019
- Received FDA Clearance for IND and Anticipate Starting Phase 1/2 pheNIX Trial for PKU Gene Therapy Candidate with Initial Data Expected by Year End - - Began IND-Enabling Studies for Two Additional Programs, Including [...]
Crinetics Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Solid Biosciences Reports First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
– Dosing of SGT-001 initiated in second cohort of patients in the IGNITE DMD clinical trial at 2E14 vg/kg – – Clinical activities underway at additional study sites – CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- [...]
Equillium Reports First Quarter 2019 Financial Results and Recent Highlights
13/05/2019
EQUATE Phase 1b/2 trial in acute graft-versus-host disease (aGVHD) ongoing with data expected in 1Q 2020 On track to initiate Phase 1b proof-of-concept trials of itolizumab (EQ001) in uncontrolled asthma and lupus [...]
NextCure Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
13/05/2019
BELTSVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
13/05/2019
PORTLAND, Maine, May 13, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and [...]
aTyr Pharma Announces First Quarter 2019 Results and Provides Corporate Update
13/05/2019
Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients ongoing Advanced lead position in Neuropilin-2 (NRP-2) biology with inaugural NRP-2 summit Company to host conference call and [...]

Pages